Back to Results
First PageMeta Content
Piperazines / Cardiac electrophysiology / QT interval / Adverse Event Reporting System / Torsades de pointes / Breast implant / Norfloxacin / Clinical research / Approved drug / Medicine / Health / Food and Drug Administration


JOURNAL OF WOMEN’S HEALTH Volume 16, Number 6, 2007 © Mary Ann Liebert, Inc. DOI: [removed]jwh[removed]Special Report
Add to Reading List

Open Document

File Size: 87,71 KB

Share Result on Facebook

City

Gender / Bethesda / Geneva / Rockville / Birmingham / New York / Washington / DC / LONDON / /

Company

M.H.S.A. / Elsevier Academic Press / Services Administration / FDA’s Center / Mary Ann Liebert Inc. / National Academy Press / Hess / 3Health Resources / /

Country

Switzerland / United States / /

Currency

CYP / USD / pence / /

Event

Product Recall / Product Issues / FDA Phase / /

Facility

Duke Clinical Research Institute / Institute of Neurological Disorders / C-Path Institute / National Institute of Child Health / /

IndustryTerm

patient groups / product developers / herbal products / data mining project / pharmacological/chemical class / imaging / implemented software programs / pharmaceuticals / chlorine gas / chemical entity / visualization tools / human pharmaceuticals / data mining / important tool / prevention of cardiovascular disease / Dear healthcare professional / software programs / retail stores / data mining analyses / data mining technology / /

MedicalCondition

Torsades de pointes / Bradycardia / foreign body carcinogenesis / ventricular arrhythmia / tissue inflammation / Drug-induced torsades de pointes / acquired long QT syndrome / heart disease / torsade de pointes / fatigue / breakthrough bleeding / specific concerns/diseases / MS / arrhythmia / Valvular heart disease / hypertension / disease / cardiovascular disease / /

MedicalTreatment

dietary supplement / oral contraceptives / breast implants / breast implant / mammoplasty / dietary supplements / intravenous infusion / Replacement surgery / /

Organization

Center for Devices and Radiological / World Health Organization / Commissioner’s Office / FDA CDER / Resources and Services Administration / Senate / Food and Agricultural Organization’s Joint Expert Committee on Food Additives / Duke Clinical Research Institute / 1Food and Drug Administration / Accounting Office / Food and Drug Administration office of Women / FDA / United States General Accounting Office / Advisory Council on Women / FDA’s Center for Drug Evaluation and Research / Department of Health / 5Food and Drug Administration / National Institute of Health / office of Minority Health and Research / Office on Women / 4National Institute of Neurological Disorders and Stroke / Society for Women / Centers for Disease Control and Prevention / CONGRESS / Joint Expert Committee on Food Additives / U.S. Food and Drug Administration / C-Path Institute / office of Research / Food Safety / Center for Drug Evaluation and Research / Department of Health and Human Services / Division of Health Center Management / Center for Biologics Evaluation and Research / Agency for Healthcare Research and Quality / National Institute of Child Health and Human Development / /

Person

David Kessler / Yee R. Sex / KATHLEEN UHL / Arch Intern / /

Position

O’Neill RT / General / Rautaharju PM / Walker / LYNDA LEE-BISHOP / Commissioner / /

Product

Fluothane / drugs / Diabetic Gastrointestinal 12/19 / Lotronex / ten prescription drugs / Propulsid / tolbutamide / atenolol / Raxar / Rezulin / Droperidol / estradiol / quinidine gluconate / individuals.37 / 40 / testosterone / PRESCRIPTION DRUGS / Date / Inapsine / review46 Tool / CYP450 / /

ProvinceOrState

Alabama / Maryland / /

Technology

proteomics / 3526 protocols / Biomaterials / gene expression / genomics / drug metabolism / bioinformatics / pharmacokinetics / pharmacogenetics / data mining technology / data mining / pharmacodynamics / drug development / /

URL

www.gao.gov/new / www.fda.gov / www.fda.gov/fdac/features/2004/504_implants.html / www.mith2.umd.edu/WomensStudies/GovernmentPolitics/CaucusUpdates/Update-vol14no4/headlines / www.fda.gov/cdrh/ode/guidance/1354.pdf / www.fda.gov/cder / www.fda.gov/cder/guidance/6885fnl.htm / www.fda.gov/womens/science.html / www.fda.gov/womens/scienceprogram/report2000/appendix.htm / www.fda.gov/womens/gender.html / www.fda.gov/ohrms/dockets/98fr/02d-0232gdl0001-vol1 / www.fda / www.fda.gov/medwatch/SAFETY/2002/geodon.htm / www.fda.gov/ohrms / www.fda.gov/womens/scienceprogram/report2000/abstracts.htm#womenclinical / /

SocialTag